$DSS
DSS, INC. Stock $dss

$dss Overview Financials Valuation SEC Filings Company Website

2023 Q2 Form 10-Q Financial Statement

#000149315223017443 Filed on May 15, 2023

Income Statement

Concept	2023 Q2	2023 Q1	2022 Q1
Revenue	$7.233M	$11.93M	$12.30M
YoY Change	-38.55%	-3.07%	175.38%
Cost Of Revenue	$4.832M	$8.533M	$5.443M
YoY Change	-37.0%	56.77%	65.54%
Gross Profit	$2.401M	$3.393M	$6.861M
YoY Change	-41.45%	-50.55%	481.44%
Gross Profit Margin	33.2%	28.45%	55.76%
Selling, General & Admin	$8.851M	$8.973M	$9.570M
YoY Change	-42.09%	-6.24%	179.82%
% of Gross Profit	368.64%	264.46%	139.48%
Research & Development	$266.0K	$179.0K	$168.0K
YoY Change	29.13%	6.55%	-31.15%
% of Gross Profit	11.08%	5.28%	2.45%
Depreciation & Amortization	$1.314M	$1.333M	$3.266M
YoY Change	-58.4%	-59.19%	535.41%
% of Gross Profit	54.73%	39.29%	47.6%
Operating Expenses	$13.68M	$17.51M	$13.60M
YoY Change	-40.39%	28.68%	197.62%
Operating Profit	-$6.450M	-$5.580M	-$6.743M
YoY Change	-42.32%	-17.25%	98.85%
Interest Expense	$138.0K	$249.0K	-$910.0K
YoY Change	14.05%	-127.36%	-43.97%
% of Operating Profit
Other Income/Expense, Net	$147.0K	-$65.00K	-$1.703M
YoY Change	-93.73%	-96.18%
Pretax Income	-$37.72M	-$8.633M	-$8.951M
YoY Change	597.28%	-3.55%	82.71%
Income Tax
% Of Pretax Income
Net Earnings	-$37.92M	-$8.035M	-$8.048M
YoY Change	715.2%	-0.16%	102.16%
Net Earnings / Revenue	-524.31%	-67.37%	-65.41%
Basic Earnings Per Share	-$0.27	-$0.06	-$0.10
Diluted Earnings Per Share	-$0.27	-$0.06	-$95.10K
COMMON SHARES
Basic Shares Outstanding	140.3M shares	139.0M shares	84.63M shares
Diluted Shares Outstanding	140.1M shares	139.0M shares	84.63M shares

Balance Sheet

Concept	2023 Q2	2023 Q1	2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$10.18M	$13.73M	$53.81M
YoY Change	-76.83%	-74.48%	3.36%
Cash & Equivalents	$10.03M	$13.70M	$53.81M
Short-Term Investments	$148.0K
Other Short-Term Assets	$2.723M	$2.043M	$1.869M
YoY Change	26.12%	9.31%	28.81%
Inventory	$5.300M	$7.262M	$9.778M
Prepaid Expenses
Receivables	$2.468M	$6.995M	$6.103M
Other Receivables	$9.269M	$11.42M	$6.739M
Total Short-Term Assets	$29.79M	$41.45M	$78.30M
YoY Change	-60.17%	-47.06%	30.77%
LONG-TERM ASSETS
Property, Plant & Equipment	$12.44M	$13.61M	$73.79M
YoY Change	-22.28%	-81.56%	1642.46%
Goodwill	$57.88M	$60.92M
YoY Change	2.25%
Intangibles
YoY Change
Long-Term Investments	$139.0K	$157.0K	$30.09M
YoY Change	-85.85%	-99.48%	11.98%
Other Assets	$261.0K	$2.754M	$557.0K
YoY Change	-67.42%	394.43%	64.79%
Total Long-Term Assets	$175.1M	$185.3M	$203.6M
YoY Change	-15.89%	-8.97%	145.46%
TOTAL ASSETS
Total Short-Term Assets	$29.79M	$41.45M	$78.30M
Total Long-Term Assets	$175.1M	$185.3M	$203.6M
Total Assets	$204.9M	$226.8M	$281.9M
YoY Change	-27.6%	-19.55%	97.38%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$3.046M	$5.095M	$2.452M
YoY Change	44.22%	107.79%	96.47%
Accrued Expenses	$3.713M	$10.26M	$17.06M
YoY Change	-70.26%	-39.84%	780.94%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$47.21M	$48.77M	$6.835M
YoY Change	1.06%	613.58%	1272.49%
Total Short-Term Liabilities	$55.49M	$64.61M	$26.74M
YoY Change	-10.08%	141.57%	516.22%
LONG-TERM LIABILITIES
Long-Term Debt	$7.218M	$5.778M	$59.40M
YoY Change	-63.11%	-90.27%	3476.04%
Other Long-Term Liabilities	$507.0K	$507.0K	$1.662M
YoY Change	0.0%	-69.49%	216.57%
Total Long-Term Liabilities	$7.725M	$6.285M	$61.06M
YoY Change	-61.52%	-89.71%	2693.23%
TOTAL LIABILITIES
Total Short-Term Liabilities	$55.49M	$64.61M	$26.74M
Total Long-Term Liabilities	$7.725M	$6.285M	$61.06M
Total Liabilities	$63.22M	$70.89M	$124.1M
YoY Change	-22.7%	-42.9%	886.41%
SHAREHOLDERS EQUITY
Retained Earnings	-$221.5M	-$202.4M
YoY Change	50.49%
Common Stock	$2.804M	$2.779M
YoY Change	40.13%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$98.64M	$117.5M	$157.7M
YoY Change
Total Liabilities & Shareholders Equity	$204.9M	$226.8M	$281.9M
YoY Change	-27.6%	-19.55%	97.38%

Cashflow Statement

Concept	2023 Q2	2023 Q1	2022 Q1
OPERATING ACTIVITIES
Net Income	-$37.92M	-$8.035M	-$8.048M
YoY Change	715.2%	-0.16%	102.16%
Depreciation, Depletion And Amortization	$1.314M	$1.333M	$3.266M
YoY Change	-58.4%	-59.19%	535.41%
Cash From Operating Activities	-$5.516M	-$14.20M	-$6.070M
YoY Change	-29.97%	133.92%	-24.53%
INVESTING ACTIVITIES
Capital Expenditures	-$98.00K	$594.0K	-$942.0K
YoY Change	188.24%	-163.06%	1208.33%
Acquisitions
YoY Change
Other Investing Activities	$1.741M	$12.13M	-$4.417M
YoY Change	-270.85%	-374.64%	-30.74%
Cash From Investing Activities	$1.839M	$11.54M	-$5.359M
YoY Change	-274.64%	-315.28%	-16.9%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net		$4.002M	$246.0K
YoY Change		1526.83%
Cash From Financing Activities	-22.00K	-$2.896M	8.645M
YoY Change	-97.65%	-133.5%	-85.85%
NET CHANGE
Cash From Operating Activities	-5.516M	-$14.20M	-6.070M
Cash From Investing Activities	1.839M	$11.54M	-5.359M
Cash From Financing Activities	-22.00K	-$2.896M	8.645M
Net Change In Cash	-3.699M	-$5.558M	-2.784M
YoY Change	-62.51%	99.64%	-105.97%
FREE CASH FLOW
Cash From Operating Activities	-$5.516M	-$14.20M	-$6.070M
Capital Expenditures	-$98.00K	$594.0K	-$942.0K
Free Cash Flow	-$5.418M	-$14.79M	-$5.128M
YoY Change	-30.92%	188.48%	-35.67%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2023Q1	dei	Entity File Number EntityFileNumber	001-32146
CY2023Q1	dei	Entity Registrant Name EntityRegistrantName	DSS, INC.
CY2023Q1	dei	Entity Central Index Key EntityCentralIndexKey	0000771999
CY2023Q1	dei	Amendment Flag AmendmentFlag	false
CY2023Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2023Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NY
CY2023Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	16-1229730
CY2023Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	275 Wiregrass Pkwy
CY2023Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	West Henrietta
CY2023Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	NY
CY2023Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	14586
CY2022Q1	us-gaap	Dividend Income Operating DividendIncomeOperating		usd
CY2023Q1	us-gaap	Gain Loss On Sales Of Assets And Asset Impairment Charges GainLossOnSalesOfAssetsAndAssetImpairmentCharges		usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation		usd
CY2022Q1	DSS	Change In Right Of Use Assets ChangeInRightOfUseAssets		usd
CY2022Q1	DSS	Change In Right Of Useliabilities ChangeInRightOfUseliabilities		usd
CY2023Q1	DSS	Impairment Of Notes Receivable And Other Investments ImpairmentOfNotesReceivableAndOtherInvestments		usd
CY2023Q1	us-gaap	Payments To Acquire Other Investments PaymentsToAcquireOtherInvestments		usd
CY2023Q1	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities		usd
CY2022Q1	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt		usd
CY2022Q1	DSS	Payment For Change In Equity Investment PaymentForChangeInEquityInvestment		usd
CY2022Q1	us-gaap	Proceeds From Sale Of Notes Receivable ProceedsFromSaleOfNotesReceivable		usd
CY2023Q1	us-gaap	Payments To Acquire Notes Receivable PaymentsToAcquireNotesReceivable		usd
CY2023Q1	DSS	Debt Conversion To Equity In Subsidiary DebtConversionToEquityInSubsidiary		usd
CY2023Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock		usd
CY2023Q1	DSS	Revenue On Management Fees Income RevenueOnManagementFeesIncome		usd
CY2023Q1	dei	Document Type DocumentType	10-Q
CY2023Q1	dei	City Area Code CityAreaCode	(585)
CY2023Q1	dei	Local Phone Number LocalPhoneNumber	325-3610
CY2023Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2023Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023Q1	dei	Entity Shell Company EntityShellCompany	false
CY2023Q1	dei	Security12b Title Security12bTitle	Common Stock, $0.02 par value per share
CY2023Q1	dei	Trading Symbol TradingSymbol	DSS
CY2023Q1	dei	Security Exchange Name SecurityExchangeName	NYSE
CY2023Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	140264250	shares
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	13732000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	19290000	usd
CY2023Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	6995000	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	7564000	usd
CY2023Q1	us-gaap	Inventory Net InventoryNet	7262000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	7721000	usd
CY2023Q1	us-gaap	Notes And Loans Receivable Net Current NotesAndLoansReceivableNetCurrent	11422000	usd
CY2022Q4	us-gaap	Notes And Loans Receivable Net Current NotesAndLoansReceivableNetCurrent	11719000	usd
CY2023Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	2043000	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1700000	usd
CY2023Q1	us-gaap	Assets Current AssetsCurrent	41454000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	47994000	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	13611000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	13391000	usd
CY2023Q1	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	54511000	usd
CY2022Q4	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	55029000	usd
CY2023Q1	us-gaap	Other Investments OtherInvestments	1562000	usd
CY2022Q4	us-gaap	Other Investments OtherInvestments	1534000	usd
CY2023Q1	us-gaap	Equity Method Investments EquityMethodInvestments	157000	usd
CY2022Q4	us-gaap	Equity Method Investments EquityMethodInvestments	162000	usd
CY2023Q1	us-gaap	Marketable Securities Noncurrent MarketableSecuritiesNoncurrent	13391000	usd
CY2022Q4	us-gaap	Marketable Securities Noncurrent MarketableSecuritiesNoncurrent	27307000	usd
CY2023Q1	us-gaap	Notes And Loans Receivable Net Noncurrent NotesAndLoansReceivableNetNoncurrent	158000	usd
CY2022Q4	us-gaap	Notes And Loans Receivable Net Noncurrent NotesAndLoansReceivableNetNoncurrent	922000	usd
CY2023Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	2754000	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	2699000	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	8203000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	8219000	usd
CY2023Q1	us-gaap	Goodwill Goodwill	60919000	usd
CY2022Q4	us-gaap	Goodwill Goodwill	60919000	usd
CY2023Q1	us-gaap	Other Intangible Assets Net OtherIntangibleAssetsNet	30030000	usd
CY2022Q4	us-gaap	Other Intangible Assets Net OtherIntangibleAssetsNet	30740000	usd
CY2023Q1	us-gaap	Assets Assets	226750000	usd
CY2022Q4	us-gaap	Assets Assets	248916000	usd
CY2023Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	5095000	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	5914000	usd
CY2023Q1	DSS	Accrued Expenses And Deferred Revenue Current AccruedExpensesAndDeferredRevenueCurrent	9461000	usd
CY2022Q4	DSS	Accrued Expenses And Deferred Revenue Current AccruedExpensesAndDeferredRevenueCurrent	19341000	usd
CY2023Q1	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	477000	usd
CY2022Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	477000	usd
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	800000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	796000	usd
CY2023Q1	us-gaap	Long Term Debt Current LongTermDebtCurrent	48773000	usd
CY2022Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	47161000	usd
CY2023Q1	us-gaap	Liabilities Current LiabilitiesCurrent	64606000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	73689000	usd
CY2023Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	5778000	usd
CY2022Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	10181000	usd
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	7773000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	7820000	usd
CY2023Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	507000	usd
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	507000	usd
CY2023Q1	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	38000	usd
CY2022Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	38000	usd
CY2023Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.02
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.02
CY2023Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	47000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	47000	shares
CY2023Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q4	us-gaap	Preferred Stock Liquidation Preference PreferredStockLiquidationPreference	1000
CY2022Q4	us-gaap	Preferred Stock Liquidation Preference Value PreferredStockLiquidationPreferenceValue	0	usd
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.02
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.02
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	139017172	shares
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	139017172	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	139017172	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	139017172	shares
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	2779000	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	2779000	usd
CY2023Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	317126000	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	317126000	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-202378000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-194343000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	117527000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	125562000	usd
CY2023Q1	us-gaap	Minority Interest MinorityInterest	30521000	usd
CY2022Q4	us-gaap	Minority Interest MinorityInterest	31119000	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	148048000	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	156681000	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	226750000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	248916000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	11926000	usd
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	12304000	usd
CY2023Q1	DSS	Cost Of Revenue Exclusive Of Depreciation And Amortization CostOfRevenueExclusiveOfDepreciationAndAmortization	8533000	usd
CY2022Q1	DSS	Cost Of Revenue Exclusive Of Depreciation And Amortization CostOfRevenueExclusiveOfDepreciationAndAmortization	8878000	usd
CY2023Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	8973000	usd
CY2022Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	10745000	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	17506000	usd
CY2022Q1	us-gaap	Operating Expenses OperatingExpenses	19623000	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-5580000	usd
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-7319000	usd
CY2023Q1	us-gaap	Investment Income Interest InvestmentIncomeInterest	130000	usd
CY2022Q1	us-gaap	Investment Income Interest InvestmentIncomeInterest	156000	usd
CY2023Q1	us-gaap	Dividend Income Operating DividendIncomeOperating	4000	usd
CY2023Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-65000	usd
CY2022Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-1703000	usd
CY2023Q1	us-gaap	Interest Expense InterestExpense	249000	usd
CY2022Q1	us-gaap	Interest Expense InterestExpense	802000	usd
CY2023Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-4000	usd
CY2022Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-112000	usd
CY2023Q1	us-gaap	Gain Loss On Investments GainLossOnInvestments	-2869000	usd
CY2022Q1	us-gaap	Gain Loss On Investments GainLossOnInvestments	424000	usd
CY2022Q1	us-gaap	Gain Loss On Sales Of Assets And Asset Impairment Charges GainLossOnSalesOfAssetsAndAssetImpairmentCharges	405000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-8633000	usd
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-8951000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-8633000	usd
CY2022Q1	us-gaap	Profit Loss ProfitLoss	-8951000	usd
CY2023Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-598000	usd
CY2022Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-903000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-8035000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-8048000	usd
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.06
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.10
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.06
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.10
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	139017172	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	84626847	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	139017172	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	84626847	shares
CY2023Q1	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-8633000	usd
CY2022Q1	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-8951000	usd
CY2023Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1333000	usd
CY2022Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	3266000	usd
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	4000	usd
CY2022Q1	DSS	Equity Method Investments Gain Loss EquityMethodInvestmentsGainLoss	112000	usd
CY2023Q1	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	-2869000	usd
CY2022Q1	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	-424000	usd
CY2023Q1	DSS	Change In Right Of Use Assets ChangeInRightOfUseAssets	-16000	usd
CY2023Q1	DSS	Change In Right Of Useliabilities ChangeInRightOfUseliabilities	43000	usd
CY2022Q1	DSS	Impairment Of Notes Receivable And Other Investments ImpairmentOfNotesReceivableAndOtherInvestments	1637000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-608000	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	430000	usd
CY2023Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-459000	usd
CY2022Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-602000	usd
CY2023Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	383000	usd
CY2022Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-1597000	usd
CY2023Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	55000	usd
CY2022Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	68000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-819000	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	532000	usd
CY2023Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-9551000	usd
CY2022Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-4697000	usd
CY2022Q1	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	126000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-14199000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-6070000	usd
CY2023Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	594000	usd
CY2022Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	942000	usd
CY2022Q1	us-gaap	Payments To Acquire Other Investments PaymentsToAcquireOtherInvestments	1085000	usd
CY2022Q1	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	4693000	usd
CY2023Q1	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	11330000	usd
CY2023Q1	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	32000	usd
CY2022Q1	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	2152000	usd
CY2023Q1	DSS	Payment For Change In Equity Investment PaymentForChangeInEquityInvestment	-5000	usd
CY2023Q1	us-gaap	Proceeds From Sale Of Notes Receivable ProceedsFromSaleOfNotesReceivable	764000	usd
CY2022Q1	us-gaap	Payments To Acquire Notes Receivable PaymentsToAcquireNotesReceivable	791000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	11537000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-5359000	usd
CY2023Q1	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	4002000	usd
CY2022Q1	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	246000	usd
CY2023Q1	us-gaap	Proceeds From Repayments Of Other Long Term Debt ProceedsFromRepaymentsOfOtherLongTermDebt	1106000	usd
CY2022Q1	us-gaap	Proceeds From Repayments Of Other Long Term Debt ProceedsFromRepaymentsOfOtherLongTermDebt	6193000	usd
CY2022Q1	DSS	Debt Conversion To Equity In Subsidiary DebtConversionToEquityInSubsidiary	840000	usd
CY2022Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	1858000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-2896000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	8645000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-5558000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-2784000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	19290000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	56595000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	13732000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	53811000	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	156681000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-8633000	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	148048000	usd
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	200304000	usd
CY2022Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	1858000	usd
CY2022Q1	us-gaap	Noncontrolling Interest Increase From Business Combination NoncontrollingInterestIncreaseFromBusinessCombination	840000	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	4000	usd
CY2022Q1	us-gaap	Profit Loss ProfitLoss	-8951000	usd
CY2022Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	194055000	usd
CY2022Q2	us-gaap	Stock Issued During Period Shares Acquisitions StockIssuedDuringPeriodSharesAcquisitions	17570948	shares
CY2023Q1	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_847_eus-gaap--UseOfEstimates_zEI3hdJ1nwz7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86C_z97xfyxPUZjc">Use of Estimates</span> - </i></b>The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States requires the Company to make estimates and assumptions that affect the amounts reported and disclosed in the financial statements and the accompanying notes. Actual results could differ materially from these estimates. On an ongoing basis, the Company evaluates its estimates, including those related to the accounts receivable, convertible notes receivable, inventory, fair values of investments, intangible assets and goodwill, useful lives of intangible assets and property and equipment, fair values of options and warrants to purchase the Company’s common stock, preferred stock, deferred revenue, and income taxes, among others. The Company bases its estimates on historical experience and on various other assumptions that are believed to be reasonable, the results of which form the basis for making judgments about the carrying values of assets and liabilities.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q1	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<p id="xdx_846_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_zNnXYZ8eUcZ" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span id="xdx_868_zaSOmWZ4gIFj" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Reclassifications </i></b></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">- For the three months ended March 31, 2022, $<span id="xdx_908_ecustom--ReclassificationFromInterestExpense_c20230101__20230331_zAimDRFvPhs4" title="Reclassification from interest expense">577,000</span> of was reclassified from Interest expense, to Cost of revenue on the consolidated income statements to conform to current period presentation.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q1	DSS	Reclassification From Interest Expense ReclassificationFromInterestExpense	577000	usd
CY2023Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	29000	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	29000	usd
CY2023Q1	us-gaap	Inventory Adjustments InventoryAdjustments	57000	usd
CY2022Q4	us-gaap	Inventory Adjustments InventoryAdjustments	742000	usd
CY2023Q1	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p id="xdx_84B_eus-gaap--ConcentrationRiskCreditRisk_zObiKbKCdfi3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_869_zRY5xq11ckud">Concentration of Credit Risk</span> </i></b><i>-</i> The Company maintains its cash in bank deposit accounts, which at times may exceed federally insured limits. The Company believes it is not exposed to any significant credit risk because of any non-performance by the financial institutions. </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of December 31, 2022, two customers accounted for approximately <span id="xdx_901_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220101__20221231__srt--MajorCustomersAxis__custom--CustomerOneMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zTC5fEWTDRci" title="Concentration risk percentage">14</span>% and <span id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220101__20221231__srt--MajorCustomersAxis__custom--CustomerTwoMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_z4ySyzPuQvUj" title="Concentration risk percentage">6</span>% of our consolidated revenue and these two customers accounted for approximately <span id="xdx_90C_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220101__20221231__srt--MajorCustomersAxis__custom--CustomerOneMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zAscDDJPbWAk">36</span>% and <span id="xdx_906_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220101__20221231__srt--MajorCustomersAxis__custom--CustomerTwoMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zNJIeQJvLcOg">17</span>% of our consolidated trade accounts receivable balance.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of March 31, 2023, one customer accounted for approximately <span id="xdx_905_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20230101__20230331__srt--MajorCustomersAxis__custom--CustomerOneMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zPNlORZ4MB11" title="Concentration risk, rate">23% of our consolidated revenue and </span></span><span id="xdx_90B_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20230101__20230331__srt--MajorCustomersAxis__custom--CustomerOneMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zxU3Lq4l9sLd" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">47</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% of our trade accounts receivable balance.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	13700000	usd
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	13700000	usd
CY2023Q1	us-gaap	Marketable Securities Noncurrent MarketableSecuritiesNoncurrent	13400000	usd
CY2023Q1	us-gaap	Convertible Debt ConvertibleDebt	12000000	usd
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	13700000	usd
CY2021Q4	us-gaap	Marketable Securities Noncurrent MarketableSecuritiesNoncurrent	13400000	usd
CY2022Q1	us-gaap	Notes And Loans Receivable Net Current NotesAndLoansReceivableNetCurrent	12000000	usd
CY2023Q1	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	29000	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	29000	usd
CY2022	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	49076804	usd
CY2022	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	-61680088	usd
CY2022	us-gaap	Business Acquisition Pro Forma Earnings Per Share Basic BusinessAcquisitionProFormaEarningsPerShareBasic	-0.55
CY2022	us-gaap	Business Acquisition Pro Forma Earnings Per Share Diluted BusinessAcquisitionProFormaEarningsPerShareDiluted	-0.55
CY2023Q1	us-gaap	Inventory Finished Goods InventoryFinishedGoods	5596000	usd
CY2022Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	6779000	usd
CY2023Q1	us-gaap	Inventory Work In Process InventoryWorkInProcess	536000	usd
CY2022Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	403000	usd
CY2023Q1	us-gaap	Inventory Raw Materials And Supplies InventoryRawMaterialsAndSupplies	1187000	usd
CY2022Q4	us-gaap	Inventory Raw Materials And Supplies InventoryRawMaterialsAndSupplies	1281000	usd
CY2023Q1	us-gaap	Inventory Gross InventoryGross	7319000	usd
CY2022Q4	us-gaap	Inventory Gross InventoryGross	8463000	usd
CY2023Q1	us-gaap	Inventory Adjustments InventoryAdjustments	57000	usd
CY2022Q4	us-gaap	Inventory Adjustments InventoryAdjustments	742000	usd
CY2023Q1	us-gaap	Inventory Net InventoryNet	7262000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	7721000	usd
CY2023Q1	us-gaap	Equity Method Investment Other Than Temporary Impairment EquityMethodInvestmentOtherThanTemporaryImpairment	38268000	usd
CY2023Q1	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-10957000	usd
CY2023Q1	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	27311000	usd
CY2023Q1	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	13732000	usd
CY2023Q1	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	13391000	usd
CY2023Q1	us-gaap	Investments Investments	188000	usd
CY2022	us-gaap	Equity Method Investment Other Than Temporary Impairment EquityMethodInvestmentOtherThanTemporaryImpairment	59894000	usd
CY2022	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-3659000	usd
CY2022Q4	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	46776000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	19290000	usd
CY2022Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	27307000	usd
CY2022Q4	us-gaap	Investments Investments	179000	usd
CY2023Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear	43275000	usd
CY2023Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	3801000	usd
CY2023Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	858000	usd
CY2023Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	901000	usd
CY2023Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	947000	usd
CY2023Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal After Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive	4769000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	941000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	1050000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	906000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	899000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	916000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	935000	usd
CY2023Q1	DSS	Lessee Operating Lease Liability Payments Due Year Six LesseeOperatingLeaseLiabilityPaymentsDueYearSix	954000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	4015000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	10616000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	2043000	usd
CY2023Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	8573000	usd
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	800000	usd
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	7773000	usd
CY2023Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P14Y3M18D
CY2023Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.043	pure
CY2023Q1	DSS	Revenue On Direct Marketing RevenueOnDirectMarketing	3994000	usd
CY2022Q1	DSS	Revenue On Direct Marketing RevenueOnDirectMarketing	6932000	usd
CY2023Q1	DSS	Revenue On Securities RevenueOnSecurities	1685000	usd
CY2022Q1	DSS	Revenue On Securities RevenueOnSecurities	1663000	usd
CY2022Q1	DSS	Revenue On Management Fees Income RevenueOnManagementFeesIncome	11000	usd
CY2023Q1	DSS	Revenue On Net Investment Income RevenueOnNetInvestmentIncome	117000	usd
CY2022Q1	DSS	Revenue On Net Investment Income RevenueOnNetInvestmentIncome	129000	usd
CY2022Q2	us-gaap	Stock Issued During Period Shares Acquisitions StockIssuedDuringPeriodSharesAcquisitions	17570948	shares
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	4000	usd
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet	249000	usd
CY2022Q1	us-gaap	Interest Paid Net InterestPaidNet	1378000	usd
	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	5	segments
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	11926000	usd
CY2023Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1334000	usd
CY2023Q1	us-gaap	Interest Expense InterestExpense	249000	usd
CY2023Q1	DSS	Interest Income InterestIncome	130000	usd
CY2023Q1	DSS	Net Income Loss From Continuing Operations NetIncomeLossFromContinuingOperations	-8633000	usd
CY2023Q1	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	594000	usd
CY2023Q1	DSS	Identifiable Assets IdentifiableAssets	226750000	usd
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	12304000	usd
CY2022Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	3266000	usd
CY2022Q1	us-gaap	Interest Expense InterestExpense	802000	usd
CY2022Q1	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	4000	usd
CY2022Q1	DSS	Net Income Loss From Continuing Operations NetIncomeLossFromContinuingOperations	-8951000	usd
CY2022Q1	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	942000	usd
CY2022Q1	DSS	Identifiable Assets IdentifiableAssets	281859000	usd
CY2023Q1	DSS	Aggregate Value Of Printed Products AggregateValueOfPrintedProducts	6130000	usd
CY2022Q1	DSS	Aggregate Value Of Printed Products AggregateValueOfPrintedProducts	3569000	usd
CY2022Q2	us-gaap	Stock Issued During Period Shares Acquisitions StockIssuedDuringPeriodSharesAcquisitions	17570948	shares

Files In Submission

Name	View Source	Status
dss-20230331_def.xml	Edgar Link	unprocessable
dss-20230331_lab.xml	Edgar Link	unprocessable
dss-20230331_cal.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
R44.htm	Edgar Link	pending
0001493152-23-017443-index-headers.html	Edgar Link	pending
0001493152-23-017443-index.html	Edgar Link	pending
0001493152-23-017443.txt	Edgar Link	pending
0001493152-23-017443-xbrl.zip	Edgar Link	pending
dss-20230331.xsd	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
ex32-2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-q.htm	Edgar Link	pending
logo_001.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
form10-q_htm.xml	Edgar Link	completed
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
dss-20230331_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$DSS
DSS, INC. Stock $dss

2023 Q2 Form 10-Q Financial Statement

#000149315223017443 Filed on May 15, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$DSS DSS, INC. Stock $dss

2023 Q2 Form 10-Q Financial Statement

#000149315223017443 Filed on May 15, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$DSS
DSS, INC. Stock $dss